Another theory.
The suitor is Sanofi and they are renegotiating the terms on their contacts as part of entering into a strategic partnership.
Hence no payment coming from Sanofi hence UNS missing their revenue target hence seeking a waiver hence Orbimed loaning another 10MM.
Just a theory.
Begs another question -- why did Orbimed's own due diligence projections fail within a year?
Strong Message to the Market, page-6
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)